• Company
  • News
  • Investors
  • Contacts
  • Careers
polypeptide-logopolypeptide-logologo-mobilepolypeptide-logo
  • Services
    • GMP Compliance
    • Pre-GMP development
    • Production
    • Quality Assurance
    • Quality control
    • Regulatory Support
  • Generic peptides
  • Commercial Manufacturing
    • Commercial products at PolyPeptide
    • Late stage development
    • Process development and optimization
    • Capacity and Capabilities
  • Custom R&D
    • Custom Research Grade Peptides
    • Radiolabeled peptide
  • Cosmetic
  • Individualized Peptides
  • Oligos
  • Services
    • GMP Compliance
    • Pre-GMP development
    • Production
    • Quality Assurance
    • Quality control
    • Regulatory Support
  • Generic peptides
  • Commercial Manufacturing
    • Commercial products at PolyPeptide
    • Late stage development
    • Process development and optimization
    • Capacity and Capabilities
  • Custom R&D
    • Custom Research Grade Peptides
    • Radiolabeled peptide
  • Cosmetic
  • Individualized Peptides
  • Oligos
✕
  • Home
  • News
  • Business news
  • Information Letter on COVID-19

Information Letter on COVID-19

23 April 2020
Business news
Letter covid19

Our company is actively engaged in helping to find treatments and cures for COVID-19.

Dear Valued Customer,

While the COVID-19 crisis continues, I want to assure you that the PolyPeptide Group remains ready to support your business. Our sites are operating at almost-full capacity. At the same time, we have put numerous steps in place to protect the health and safety of our employees, including rigorous cleaning and infection control procedures.

Our company is also actively engaged in helping to find treatments and cures for COVID-19. Within the next few weeks, we will have teams at almost all sites working on projects to:

  1. Develop a peptide-based vaccine or vaccine cocktail against the virus
  2. Use peptides as immuno-modulators to allow our own immune system to fight this disease
  3. Use anti-inflammatory peptides to fight the excessive release of cytokines that this disease may cause
  4. Develop entry-inhibiting peptides that may inhibit coronavirus’ ability to enter human lung cells

We would be honored to help further your projects to combat the virus.

Our lines of communication remain open as we work to support your projects, your business, and your patients. Thank you for your ongoing partnership during this challenging time.

Wishing you and your family good health,

Kind regards,

 

Jane Salik, CEO

Download letter PDF here

Back to news

Related posts

8 May 2023

PolyPeptide launches new “Innovation Lab”


Read more
9 November 2022

FluoGuide reaches milestone with FG001 for phase III clinical supply


Read more
28 June 2022

PolyPeptide wins Malmö Life Science Business Award


Read more

Polypeptide Group

INFO

COMPANY
LEADERSHIP
CONTACTS
CAREERS

NEWS

LATEST NEWS
SIGN UP FOR NEWS
EVENTS

SOCIALS

LINKEDIN
YOUTUBE
© Confidentiality 2021 PolyPeptide Group • Cookie management • Personal data • Sitemap • Confidentiality policy
    • Company
    • News
    • Investors
    • Contacts
    • Careers
    By clicking “Accept”, you consent to the use of ALL the cookies on our website . However you may visit Cookie Settings to provide a controlled consent.
    Cookie settingsACCEPT
    Privacy & Cookies Policy

    Privacy Overview

    You can enable or disable your consent for each category of cookie.

    More information on the collection of personal data
    Necessary
    Always Enabled

    The necessary cookies help to make a website usable by enabling basic functions such as page navigation and access to secure areas of the website. The website cannot function properly without these cookies.

    Advertisement

    Marketing cookies are used to track visitors through websites. The goal is to display ads that are relevant and interesting to the individual user and therefore more valuable to third-party publishers and advertisers.

    Analytics

    Statistical cookies help website owners, through the anonymous collection and communication of information, to understand how visitors interact with websites.

    Performance

    Preferences cookies allow a website to retain information that changes the way the site behaves or displays, such as your preferred language or the region in which you are located.

    Save & Accept